Intuitive Surgical Stock To $699?
Intuitive Surgical (ISRG) stock has jumped 20% during the past month, and is currently trading at $544.21. Our multi-factor assessment suggests that it may be time to buy more shares of ISRG stock. We have, overall, a positive view of the stock, and a price of $699 may not be out of reach. We believe there is not much to fear in ISRG stock given its overall Very Strong operating performance and financial condition. Hence, despite its Very High valuation, the stock appears Attractive but Volatile.
Below is our assessment:
| CONCLUSION | |
|---|---|
| What you pay: | |
| Valuation | Very High |
| What you get: | |
| Growth | Very Strong |
| Profitability | Very Strong |
| Financial Stability | Very Strong |
| Downturn Resilience | Moderate |
| Operating Performance | Very Strong |
| Stock Opinion | Attractive but Volatile |
Portfolio beats stock-picking every time. Consider what could long-term performance for your portfolio be if you combined 10% commodities, 10% gold, and 2% crypto with equities.
Let’s get into details of each of the assessed factors but before that, for quick background: With $194 Bil in market cap, Intuitive Surgical provides advanced robotic surgical systems that enhance minimally invasive procedures, improving quality and access to complex surgeries for healthcare providers globally.
- Pay Less, Gain More: PODD Tops Intuitive Surgical Stock
- S&P 500 Movers | Winners: ISRG, AVY, HAL | Losers: LII, NFLX, PWR
- Why PODD Could Outperform Intuitive Surgical Stock
- Here’s Why Intuitive Surgical Stock Remains A Great Pick Despite Its Recent Surge
- How Will Intuitive Surgical Stock React To Its Upcoming Earnings?
- ISRG Near Crucial Support Level – Buy Signal Ahead
[1] Valuation Looks Very High
| ISRG | S&P 500 | |
|---|---|---|
| Price-to-Sales Ratio | 20.0 | 3.2 |
| Price-to-Earnings Ratio | 69.8 | 23.6 |
| Price-to-Free Cash Flow Ratio | 84.5 | 20.6 |
This table highlights how ISRG is valued vs broader market. For more details see: ISRG Valuation Ratios
[2] Growth Is Very Strong
- Intuitive Surgical has seen its top line grow at an average rate of 16.3% over the last 3 years
- Its revenues have grown 22% from $7.9 Bil to $9.6 Bil in the last 12 months
- Also, its quarterly revenues grew 22.9% to $2.5 Bil in the most recent quarter from $2.0 Bil a year ago.
| ISRG | S&P 500 | |
|---|---|---|
| 3-Year Average | 16.3% | 5.3% |
| Latest Twelve Months* | 22.2% | 5.6% |
| Most Recent Quarter (YoY)* | 22.9% | 6.6% |
This table highlights how ISRG is growing vs broader market. For more details see: ISRG Revenue Comparison
[3] Profitability Appears Very Strong
- ISRG last 12 month operating income was $2.8 Bil representing operating margin of 29.3%
- With cash flow margin of 30.8%, it generated nearly $3.0 Bil in operating cash flow over this period
- For the same period, ISRG generated nearly $2.7 Bil in net income, suggesting net margin of about 28.6%
| ISRG | S&P 500 | |
|---|---|---|
| Current Operating Margin | 29.3% | 18.8% |
| Current OCF Margin | 30.8% | 20.3% |
| Current Net Income Margin | 28.6% | 12.8% |
This table highlights how ISRG profitability vs broader market. For more details see: ISRG Operating Income Comparison
[4] Financial Stability Looks Very Strong
- ISRG Debt was $0.0 at the end of the most recent quarter, while its current Market Cap is $194 Bil. This implies Debt-to-Equity Ratio of 0.0%
- ISRG Cash (including cash equivalents) makes up $4.9 Bil of $19 Bil in total Assets. This yields a Cash-to-Assets Ratio of 25.4%
| ISRG | S&P 500 | |
|---|---|---|
| Current Debt-to-Equity Ratio | 0.0% | 20.8% |
| Current Cash-to-Assets Ratio | 25.4% | 7.0% |
[5] Downturn Resilience Is Moderate
ISRG saw an impact slightly worse than the S&P 500 index during various economic downturns. We assess this based on both (a) how much the stock fell and, (b) how quickly it recovered.
2022 Inflation Shock
- ISRG stock fell 49.9% from a high of $365.42 on 8 November 2021 to $183.06 on 14 October 2022 vs. a peak-to-trough decline of 25.4% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 18 January 2024
- Since then, the stock increased to a high of $610.45 on 22 January 2025 , and currently trades at $544.21
| ISRG | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -49.9% | -25.4% |
| Time to Full Recovery | 461 days | 464 days |
2020 Covid Pandemic
- ISRG stock fell 40.5% from a high of $206.10 on 20 February 2020 to $122.58 on 23 March 2020 vs. a peak-to-trough decline of 33.9% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 17 July 2020
| ISRG | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -40.5% | -33.9% |
| Time to Full Recovery | 116 days | 148 days |
2008 Global Financial Crisis
- ISRG stock fell 75.9% from a high of $39.32 on 10 April 2008 to $9.48 on 2 March 2009 vs. a peak-to-trough decline of 56.8% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 1 March 2010
| ISRG | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -75.9% | -56.8% |
| Time to Full Recovery | 364 days | 1480 days |
But the risk is not limited to major market crashes. Stocks fall even when markets are good – think events like earnings, business updates, outlook changes. Read ISRG Dip Buyer Analyses to see how the stock has recovered from sharp dips in the past.
The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – S&P 500, Russell, and S&P midcap. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.